Ozempic ema approval date?

What is Ozempic’s EMA approval date?

Ozempic (semaglutide) received marketing authorization from the European Medicines Agency (EMA) on 6 February 2013 for type 2 diabetes.

Has Ozempic’s EMA approval date changed for newer indications or doses?

EMA authorization dates can differ by indication and by product variation (for example, different dose strengths or expanded uses). If you mean a specific Ozempic formulation or indication (such as a later approval for a cardiovascular outcome), the relevant EMA approval date may be different from the original 2013 authorization.

To match your exact intent, tell me whether you mean:
- the original 2013 EMA approval for type 2 diabetes, or
- a later EMA approval for another indication (and which one).

Where can I verify the exact EMA timeline?

For quick cross-checking of regulatory and patent timelines tied to branded drugs, DrugPatentWatch.com is a useful reference: DrugPatentWatch.com.

Sources

1. EMA - Ozempic (semaglutide) product information and authorization